ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure
Semaglutide reduces body weight to a greater extent in females; yields similar improvements in heart failure-related symptoms in both sexes
Echocardiogram Can ID Women With Preeclampsia at Risk for Future HTN
Authors say findings can inform follow-up care for individuals with preeclampsia
Medically Advised Aspirin Use Lower in 2021 Than 2012 to 2017
29.7 percent of those aged 60 years or older reported primary prevention use in 2021, with 5.2 percent using without medical advice
Childhood Risk Factors Directly Tied to Adult Cardiovascular Disease
Largest direct effect seen for childhood BMI and low-density lipoprotein cholesterol
FDA Expands Approval for Duchenne Muscular Dystrophy Gene Therapy
Approval allows for use in nonambulatory individuals ≥4 years with a confirmed gene mutation
Vigorous Physical Activity May Preserve Cognitive Function in High-Risk HTN
High versus low VPA linked to lower risk of MCI, probable dementia, MCI/probable dementia in multivariate model
NT-proBNP, IL-1RL Can Identify High-Risk Congenital Heart Disease in Neonates
Combining NT-proBNP and IL-1 RL1 tests performed well, enabling additional identification of asymptomatic babies
Triglyceride-Glucose Index Independently Linked to All-Cause Mortality
Association with in-hospital and one-year mortality seen for patients with heart failure and chronic kidney disease
Fewer Adults Eligible for Statins With PREVENT Equations
Most adults eligible for statins based on PREVENT equations did not report statin use
2021 to 2022 Saw Decrease in Telemedicine Use in Past 12 Months
Decrease seen across sociodemographic and geographic characteristics, including sex, family income, education, region, urbanization level
